Dec. 3, 2024 — Scientists created a new therapeutic design for glioblastoma, the deadliest form of brain cancer. The lab engineered molecules called trispecifics that connect cancer-killing T ...
In a paper recently published in the journal Acta Neuropathologica Communications, DetermaCNI showed promise as a liquid biopsy method for diagnosing and profiling central nervous system tumors by ...
Brain cancer originates in the brain and consists of brain cancer cells. But brain metastases from lung cancer occur when cancer cells break off from the tumor in the lungs and enter the ...
Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding its DetermaCNI assay. In ...